A Request for APOE Testing in a Patient With a Family History of Early Dementia
A 52-year-old woman requests APOE genotyping because her father developed Alzheimer disease at 58 and her paternal aunt at 62. She is asymptomatic, has two teenage children, and says she wants to "know her fate" and "plan her life." She has read that APOE4 increases risk and wants to know if she carries two copies. She also asks whether her children should be tested. There is no known family history of early-onset autosomal dominant Alzheimer disease, and no genetic testing has been done on her father. She has mild anxiety and no current neurologic symptoms.
1. How should the counselor address the request for APOE testing, including its predictive limits and the early-onset family history?
Read the worked answer
The counselor should clarify that APOE is a susceptibility gene, not a deterministic one: APOE4 increases risk and lowers average age of onset, but many carriers never develop Alzheimer disease and many non-carriers do. A two-copy result does not mean she will develop the disease, and a negative result does not guarantee protection. The family history of onset at 58 and 62 is a red flag for possible early-onset autosomal dominant disease (APP, PSEN1, PSEN2), for which APOE testing is not the appropriate test. The counselor should recommend that the affected father (if living and willing) be tested first, since a pathogenic variant identified in him would allow predictive testing of the daughter with a clear, actionable result. APOE testing in an asymptomatic person with anxiety should be preceded by formal pre-test counseling about the psychological and insurance implications and the limited clinical utility, and the counselor should explore her motivations and support system before proceeding.
2. What is the appropriate response to her question about testing her teenage children?
Read the worked answer
The counselor should explain that predictive testing of minors for adult-onset conditions is generally not recommended when there is no medical benefit during childhood, and that APOE testing in particular has no established childhood utility. The children should not be tested at the parents' request; the decision belongs to them as adults. The counselor should acknowledge the mother's wish to protect her children and redirect toward what is helpful now-discussing family history, general brain-health measures, and leaving the option open for the children to seek counseling themselves later. If a pathogenic early-onset variant were later identified in the father and the mother were found to carry it, the counselor would still defer testing the children until adulthood, while offering them information and support.
3. If the father is deceased and no tissue is available, how should the counselor proceed?
Read the worked answer
The counselor should explain that without an affected relative to test, the family cannot determine whether the early-onset history reflects a dominantly inherited mutation, and APOE testing would not resolve that question. The counselor should offer what is possible: a genetics evaluation of the family history, review of any available records or stored tissue, and consideration of testing the affected paternal aunt if she is living and willing. If no affected relative can be tested, the counselor should discuss the limitations of proceeding with APOE alone, the uncertainty it would leave, and the option to defer testing until more information is available. The counselor should also address the patient's anxiety, offer psychological support, and document that testing was discussed but not pursued because it would not answer her central question.